IL17A and breast carcinoma: Furthermore, while analyzing 207 breast cancer specimens by IL-17 immunohistochemistry, Chen et al. found a correlation between large numbers of IL-17+ cells and high histological grade of the tumors, triple negative molecular subtype, and shorter disease-free survival [14].